Log In
Print this Print this

darbopoietin alfa (JR-131)

  Manage Alerts
Collapse Summary General Information
Company JCR Pharmaceuticals Co. Ltd.
DescriptionRDNA origin darbopoietin alfa manufactured using serum-free culture technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard Indication Renal (unspecified)
Indication DetailsTreat renal anemia; Treat renal anemia patients with chronic kidney disease (CKD)
Regulatory Designation
PartnerKissei Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today